Indications
Treatment of schizophrenia in adults aged 18 years and over.
Composition
- Active substance
- lurasidone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Latuda
- Active substance
- lurasidone
- ATC code
- N05AE05
- Group
- Nervous system
- Therapeutic area
- Schizophrenia
- Marketing authorisation holder
- Aziende Chimiche Riunite Angelini Francesco S.p.A.
- Status
- Authorised
- EU authorisation
- 21 Mar 2014
- EMA product number
- EMEA/H/C/002713